A higher COL6A3 level was also significantly correlated with lymph node metastasis and poor prognosis in GC patients, while high levels of SERPINH1 and PLEKHG1 mRNA expression were correlated with lower overall survival (OS) in GC patients [30]. This evidence concerns the gene COL6A3 and gastric cancer.